Skip to content
Economic data puts the U.S Dollar in focus late in the day. Ahead of the stats, Brexit, any chatter from Washington or Beijing, and COVID-19 will need monitoring....
Join this free webinar and discover how electrifying your fleet can improve driver retention and transform your bottom line. ...
Novavax, Inc (NASDAQ: NVAX) said Thursday it was launching a large-scale diverse Phase 3 study of its COVID-19 vaccine in the United Kingdom -- causing a more than 7% spike in the company's shares after the closing bell.What Happened: The study will enroll up to 100,000 individuals, aged between 18-84 years of age, with and without relevant comorbidities, Novavax said in a statement.The drugmaker said that the trial is being conducted in partnership with the U.K. government's Vaccines Taskforce and will last over the next four to six weeks.The Maryland-based drugmaker will enroll at least 25% of participants over the age of 65 to prioritize groups it said were most affected by COVID-19, which includes racial and ethnic minorities.Why It Matters: Novavax said it has secured $2 billion in funding for its worldwide vaccine program, which includes $388 million from the Coalition for Epidemic Preparedness Innovations, co-founded by the Bill &...
Ken Feinberg, who is mediating talks, said his "optimism knows no bounds," and that he expected the next set of cases scheduled for trial to soon settle. U.S. District Judge Vince Chhabria in San Francisco kept a stay on litigation until Nov. 2 and asked the parties for a status update at that time. Bayer, which acquired Roundup with its purchase of Monsanto for $63 billion in 2018, agreed in June to pay around $11 billion to settle the lawsuits, which have pummeled the company's share price....
With the iPhone 12 launch around the corner, all eyes are on Apple (AAPL). The launch is set to come in the next quarter, and investors are eagerly waiting to see what the tech giant has up its sleeve.5-star analyst Chris Caso, of Raymond James, tells clients that based on production checks conducted across the iPhone supply chain last week, total production estimates are in-line with the Street’s calls. That being said, he points to mix as a potential driver of significant upside.“Current production plans suggest the most favorable mix we’ve ever seen for an iPhone launch, and the introduction of a fourth iPhone model at a price between iPhone 12 and iPhone 12 Pro will also help to boost blended average selling prices (ASPs). While the stock has already had a strong run since our upgrade last summer, we don’t yet think all the benefits of what we expect to...
(Bloomberg) -- Palantir Technologies Inc.’s bankers have told investors that its shares could start trading at about $10 each, which would value the data-mining company at almost $22 billion on a fully diluted basis, Dow Jones reports, citing unidentified people familiar with the matter.Palantir is planning to go public on Sept. 30 through a direct listing, an alternative to a traditional initial public offering in which the company doesn’t issue new shares to raise capital. Rather, current investors can place their shares on the market when trading begins.A representative for Palantir declined to comment.The company was previously valued by investors in 2015 at $20 billion, but its estimated valuation had fallen in the years since. This month, research firm PitchBook valued Palantir at $8.8 billion.Unlike a traditional IPO, no shares of a company in a direct listing are sold until they start trading on the exchange. Bankers advising the firm --...
